{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447812939
| IUPAC_name = (''RS'')-1-(4-chlorophenyl)-4-dimethylamino-2,3-dimethyl-butan-2-ol
| image = clobutinol.png
| width = 240
| chirality = [[Racemic mixture]]
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|clobutinol}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  Withdrawn 
<sub>(EU)</sub>| routes_of_administration =  oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 14860-49-2
| ATC_prefix = R05
| ATC_suffix = DB03
| PubChem = 26937
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1474889
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB09004
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 25085
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1NY2IX043A
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07716

<!--Chemical data-->
| C=14 | H=22 | Cl=1 | N=1 | O=1 
| molecular_weight = 255.783 g/mol
| smiles = Clc1ccc(cc1)CC(O)(C)C(C)CN(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H22ClNO/c1-11(10-16(3)4)14(2,17)9-12-5-7-13(15)8-6-12/h5-8,11,17H,9-10H2,1-4H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = KVHHQGIIZCJATJ-UHFFFAOYSA-N
}}

'''Clobutinol''' is a [[cough suppressant]] distributed by [[Boehringer-Ingelheim]], [[Novartis]]'s Hexal ([[Sandoz]]), Stada and possibly other companies.

==Side effects and withdrawal==
Studies in 2004 had indicated that clobutinol has the potential to prolong the [[QT interval]].<ref name="pmid15280442">{{Cite journal 
| last1 = Bellocq | first1 = C. 
| last2 = Wilders | first2 = R. 
| last3 = Schott | first3 = J. J. 
| last4 = Louérat-Oriou | first4 = B. 
| last5 = Boisseau | first5 = P. 
| last6 = Le Marec | first6 = H. 
| last7 = Escande | first7 = D. 
| last8 = Baró | first8 = I. 
| doi = 10.1124/mol.104.001065 
| title = A Common Antitussive Drug, Clobutinol, Precipitates the Long QT Syndrome 2 
| journal = Molecular Pharmacology 
| volume = 66 
| issue = 5 
| pages = 1093–1102 
| year = 2004 
| pmid = 15280442 
| pmc = 
}}</ref>
Clobutinol was in 2007 determined to cause [[cardiac arrhythmia]] in some patients.<ref>
{{ cite web 
| url = http://www.bfarm.de/DE/BfArM/Presse/mitteil2007/pm20-2007.html 
| title = Clobutinol-haltige Arzneimittel: BfArM ordnet Widerruf der Zulassung an. 
| publisher = BfArM (German Federal Institute for Drugs and Medical Devices) 
| date = 2007-08-31 
| quote = Clobutinol: BfArM orders cancellation of approval 
| deadurl = yes 
| archiveurl = https://web.archive.org/web/20120401035256/http://www.bfarm.de/DE/BfArM/Presse/mitteil2007/pm20-2007.html 
| archivedate = 2012-04-01 
| df =  
}}</ref>

[[Boehringer Ingelheim]] products containing clobutinol were voluntarily withdrawn from sale in [[Germany]], and the rest of the world, on August 31, 2007.<ref>
{{ cite web 
| url = http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2007/31_august_2007.html 
| publisher = Boehringer Ingelheim 
| date = 2007-08-31 
| title = Boehringer Ingelheim voluntarily withdraws its clobutinol containing medications. 
| deadurl = yes 
| archiveurl = https://web.archive.org/web/20120127070831/http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2007/31_august_2007.html 
| archivedate = 2012-01-27 
| df =  
}}</ref>

The approval for Germany and the EU was revoked in 2008.<ref>
{{ cite web 
| title = Cancellation of approval 
| url = http://www.bfarm.de/SharedDocs/1_Downloads/DE/Pharmakovigilanz/stufenplverf/globutinol_bescheid_080613.pdf?__blob=publicationFile 
| format = pdf 
| quote = Die Zulassungen für die o.g. Arzneimittel werden mit sofortiger Wirkung widerrufen. 
| publisher = BfArM (German Federal Institute for Drugs and Medical Devices) 
| date = 2008-06-06 
| deadurl = yes 
| archiveurl = https://web.archive.org/web/20120401034947/http://www.bfarm.de/SharedDocs/1_Downloads/DE/Pharmakovigilanz/stufenplverf/globutinol_bescheid_080613.pdf?__blob=publicationFile 
| archivedate = 2012-04-01 
| df =  
}}</ref>

==See also==
* [[QT interval]]
* [[Long QT syndrome]]

==References==
{{reflist}}

{{Cough and cold preparations}}

[[Category:Antitussives]]
[[Category:Chloroarenes]]
[[Category:Amines]]
[[Category:Alcohols]]

{{respiratory-system-drug-stub}}